Anne-Mieke Vandamme
AuthID: R-000-Q27
241
TÃTULO: Validation of molecular indicators of resistance transmission (MIRTs) for epidemiological studies of drug resistance transmission in HIV
AUTORES: van de Vijver, D; Brenner, B; Turner, D; Sandstrom, P; Dunn, D; Green, H; Bennett, D; Heneine, W; Shafer, R; Leitner, T; Costagliola, D; Vandamme, AM; Wainberg, M; Boucher, C; Schuurman, R;
PUBLICAÇÃO: 2004, FONTE: 13th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 9, NÚMERO: 4
AUTORES: van de Vijver, D; Brenner, B; Turner, D; Sandstrom, P; Dunn, D; Green, H; Bennett, D; Heneine, W; Shafer, R; Leitner, T; Costagliola, D; Vandamme, AM; Wainberg, M; Boucher, C; Schuurman, R;
PUBLICAÇÃO: 2004, FONTE: 13th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 9, NÚMERO: 4
INDEXADO EM: 
WOS
WOS NO MEU: 
ORCID | ResearcherID
ORCID | ResearcherID242
TÃTULO: L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients
AUTORES: Abecasis, A; Gomes, P; Derdelinckx, I; Carvalho, AP; Diogo, I; Goncalves, F; Cabanas, J; Lobo, MC; Vandamme, AM; Camacho, R;
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
AUTORES: Abecasis, A; Gomes, P; Derdelinckx, I; Carvalho, AP; Diogo, I; Goncalves, F; Cabanas, J; Lobo, MC; Vandamme, AM; Camacho, R;
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID243
TÃTULO: Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions
AUTORES: Kantor, R; Carvalho, AP; Wynhoven, B; Soares, MA; Cane, P; Clarke, J; Snoeck, J; Pillay, C; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Cahn, P; Brigido, LF; Grossman, Z; Soriano, V; Sugiura, W; Phanuphak, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
AUTORES: Kantor, R; Carvalho, AP; Wynhoven, B; Soares, MA; Cane, P; Clarke, J; Snoeck, J; Pillay, C; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Cahn, P; Brigido, LF; Grossman, Z; Soriano, V; Sugiura, W; Phanuphak, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID244
TÃTULO: Comparison of five interpretation algorithms for the prediction of protease inhibitor susceptibility in HIV-1 non-B subtypes
AUTORES: Snoeck, J; Kantor, R; Shafer, RW; Derdelinckx, I; Carvalho, AP; Wynhoven, B; Soares, MA; Cane, P; Clarke, J; Pillay, C; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Van Laethem, K; Brun Vezinet, F; Reid, C; Cahn, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
AUTORES: Snoeck, J; Kantor, R; Shafer, RW; Derdelinckx, I; Carvalho, AP; Wynhoven, B; Soares, MA; Cane, P; Clarke, J; Pillay, C; Sirivichayakul, S; Ariyoshi, K; Holguin, A; Rudich, H; Rodrigues, R; Bouzas, MB; Van Laethem, K; Brun Vezinet, F; Reid, C; Cahn, P; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID245
TÃTULO: Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study
AUTORES: Wensing, AMJ; van de Vijver, DAMC; Asjo, B; Balotta, C; Camacho, R; de Mendoza, C; Deroo, S; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, A; Horban, A; Korn, K; Kuecherer, C; Nielsen, C; Ormaasen, V; Perrin, L; Paraskevis, D; Puchhammer, E; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
AUTORES: Wensing, AMJ; van de Vijver, DAMC; Asjo, B; Balotta, C; Camacho, R; de Mendoza, C; Deroo, S; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, A; Horban, A; Korn, K; Kuecherer, C; Nielsen, C; Ormaasen, V; Perrin, L; Paraskevis, D; Puchhammer, E; ...Mais
PUBLICAÇÃO: 2003, FONTE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, NÚMERO: 3
INDEXADO EM: WOS
WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID246
TÃTULO: Abstracts from the 8th European and the 1st Brazilian workshops on virus evolution and molecular epidemiology Preface
AUTORES: Vandamme, AM;
PUBLICAÇÃO: 2003, FONTE: INFECTION GENETICS AND EVOLUTION, VOLUME: 2, NÚMERO: 3
AUTORES: Vandamme, AM;
PUBLICAÇÃO: 2003, FONTE: INFECTION GENETICS AND EVOLUTION, VOLUME: 2, NÚMERO: 3
247
TÃTULO: env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors (vol 46, pg 3954, 2002)
AUTORES: Fikkert, V; Cherepanov, P; Van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2003, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 47, NÚMERO: 3
AUTORES: Fikkert, V; Cherepanov, P; Van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2003, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 47, NÚMERO: 3
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID248
TÃTULO: Mosaic genomes of the six major primate lentivirus lineages revealed by phylogenetic analyses
AUTORES: Salemi, M; De Oliveira, T; Courgnaud, V; Moulton, V; Holland, B; Cassol, S; Switzer, WM; Vandamme, AM;
PUBLICAÇÃO: 2003, FONTE: JOURNAL OF VIROLOGY, VOLUME: 77, NÚMERO: 13
AUTORES: Salemi, M; De Oliveira, T; Courgnaud, V; Moulton, V; Holland, B; Cassol, S; Switzer, WM; Vandamme, AM;
PUBLICAÇÃO: 2003, FONTE: JOURNAL OF VIROLOGY, VOLUME: 77, NÚMERO: 13
NO MEU: ORCID | ResearcherID
ORCID | ResearcherID249
TÃTULO: HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms
AUTORES: Ravela, J; Betts, BJ; Brun Vezinet, F; Vandamme, AM; Descamps, T; Van Laethem, K; Smith, K; Schapiro, JM; Winslow, DL; Reid, C; Shafer, RW;
PUBLICAÇÃO: 2003, FONTE: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 33, NÚMERO: 1
AUTORES: Ravela, J; Betts, BJ; Brun Vezinet, F; Vandamme, AM; Descamps, T; Van Laethem, K; Smith, K; Schapiro, JM; Winslow, DL; Reid, C; Shafer, RW;
PUBLICAÇÃO: 2003, FONTE: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 33, NÚMERO: 1
INDEXADO EM: 
Scopus WOS
Scopus WOS NO MEU: ORCID | ResearcherID
ORCID | ResearcherID250
TÃTULO: Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women Full Text
AUTORES: Sanchez Palacios, C; Gotuzzo, E; Vandamme, AM; Maldonado, Y;
PUBLICAÇÃO: 2003, FONTE: International Journal of Infectious Diseases, VOLUME: 7, NÚMERO: 2
AUTORES: Sanchez Palacios, C; Gotuzzo, E; Vandamme, AM; Maldonado, Y;
PUBLICAÇÃO: 2003, FONTE: International Journal of Infectious Diseases, VOLUME: 7, NÚMERO: 2
INDEXADO EM: Scopus
Scopus NO MEU: ORCID
ORCID